Candel Therapeutics Inc

-0.13 (-3.51%)
Earnings Announcements

Candel Posts Quarterly Earnings Per Share $0.05

Published: 03/29/2022 12:16 GMT
Candel Therapeutics Inc (CADL) - Candel Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Highlights.
Candel Therapeutics Inc- Cash and Cash Equivalents As of December 31, 2021 Were $82.6 Million.
Candel Therapeutics- Expects Existing Cash, Cash Equivalents, Including $20 Million in Term Loan Proceeds, Sufficient to Fund Operations Into Q4 of 2023.
Candel Therapeutics Inc - Qtrly Earnings per Share $0.05.
Revenue is expected to be $0.01 Million
Adjusted EPS is expected to be -$0.32

Next Quarter Revenue Guidance is expected to be $0.01 Million
Next Quarter EPS Guidance is expected to be -$0.38

More details on our Analysts Page.